Evidence map›Paper›PMID 25861698›Full record

ArticleBiological psychiatry2016

Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder.

James J H Rucker, Katherine E Tansey, Margarita Rivera, Dalila Pinto, Sarah Cohen-Woods, Rudolf Uher, Katherine J Aitchison, Nick Craddock, Michael J Owen, Lisa Jones and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The genetics of neuropsychiatric disorders.Brain and neuroscience advances · 2019
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 8 countries.

James J H RuckerMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London. Electronic address: james.rucker@kcl.ac.uk.
Katherine E TanseyMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom.
Margarita RiveraMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; Section of Psychiatry, Institute of Neurosciences, Biomedical Research Centre, CIBERSAM, University of Granada, Granada, Spain.
Dalila PintoThe Centre for Applied Genomics and Program in Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Psychiatry and Genetics and Genomic Sciences, Seaver Autism Center, The Mindich Child Health & Development Institute, Mount Sinai School of Medicine, New York, New York.
Sarah Cohen-WoodsMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom.
Rudolf UherMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Katherine J AitchisonMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.
Nick CraddockMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom.
Michael J OwenMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom.
Lisa JonesDepartment of Psychiatry, University of Birmingham, Birmingham, United Kingdom.
Ian JonesMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom.
Ania KorszunBarts and The London School of Medicine and Denistry, Queen Mary University of London, London, United Kingdom.
Michael R BarnesGlaxoSmithKline, Verona, Italy, and Greenford.
Martin PreisigDepartment of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
Ole MorsCentre of Psychiatric Research, Aarhus University Hospital, Risskov, Denmark.
Wolfgang MaierDepartment of Psychiatry, University of Bonn, Bonn, Germany.
John RiceDepartment of Psychiatry, Washington University, St Louis, Missouri.
Marcella RietschelCentral Institute of Mental Health, Mannheim.
Florian HolsboerMax Planck Institute of Psychiatry (FH), Munich, Germany.
Anne E FarmerMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London.
Ian W CraigMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom.
Stephen W SchererThe Centre for Applied Genomics and Program in Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada; McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Peter McGuffinMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London.
Gerome BreenMedical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom; National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London.
Medical Research Council · GBKing's College London · GBAarhus University Hospital · DKCentral Institute of Mental Health · DEDalhousie University · CAGlaxoSmithKline (Italy) · ITIcahn School of Medicine at Mount Sinai · USMax Planck Institute of Psychiatry · DENational Institute for Health Research · GBQueen Mary University of London · GBUniversidad de Granada · ESUniversity Hospital of Lausanne · CHUniversity of Alberta · CAUniversity of Birmingham · GBUniversity of Bonn · DEUniversity of Toronto · CAWashington University in St. Louis · US

Funding

Medical Research Council G0701420Medical Research Council MR/L010305/1Wellcome TrustWellcome Trust 086635
6 · The paper itself

Abstract

backgroundDefining the molecular genomic basis of the likelihood of developing depressive disorder is a considerable challenge. We previously associated rare, exonic deletion copy number variants (CNV) with recurrent depressive disorder (RDD). Sex chromosome abnormalities also have been observed to co-occur with RDD.

methodsIn this reanalysis of our RDD dataset (N = 3106 cases; 459 screened control samples and 2699 population control samples), we further investigated the role of larger CNVs and chromosomal abnormalities in RDD and performed association analyses with clinical data derived from this dataset.

resultsWe found an enrichment of Turner's syndrome among cases of depression compared with the frequency observed in a large population sample (N = 34,910) of live-born infants collected in Denmark (two-sided p = .023, odds ratio = 7.76 [95% confidence interval = 1.79-33.6]), a case of diploid/triploid mosaicism, and several cases of uniparental isodisomy. In contrast to our previous analysis, large deletion CNVs were no more frequent in cases than control samples, although deletion CNVs in cases contained more genes than control samples (two-sided p = .0002).

conclusionsAfter statistical correction for multiple comparisons, our data do not support a substantial role for CNVs in RDD, although (as has been observed in similar samples) occasional cases may harbor large variants with etiological significance. Genetic pleiotropy and sample heterogeneity suggest that very large sample sizes are required to study conclusively the role of genetic variation in mood disorders.

Indexed as

Genome-Wide Association StudyAdolescentAdultCase-Control StudiesChromosome AberrationsDatabases, GeneticDepressive DisorderDNA Copy Number VariationsFemaleGenetic Predisposition to DiseaseHumansLinear ModelsMaleMiddle AgedYoung AdultAffective disordersCopy number variationDepressionGeneticsPhenotypes

Identifiers

PMID25861698
PMCPMC4725574
OpenAlexW2053279770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.